Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder
VANCOUVER, British Columbia, May 22, 2024 -- Optimi Health Corp. , a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as...